About
Research
Patient Care
Education
Community
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
RFA-CA-23-008. Revision applications due dates March 1, 2023 and September 1, 2023.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
RFA-CA-23-009. Revision applications due dates March 1, 2023 and September 1, 2023.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
RFA-CA-23-010. Revision applications due dates March 1, 2023 and September 1, 2023.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
RFA-CA-23-011. Revision applications due dates March 1, 2023 and September 1, 2023.
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional
RFA-FD-23-008. Applications Due February 27, 2023.
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional)
PAR-22-092. Multiple application deadlines. Expiration date: September 8, 2024
2023-24 Faculty Seed Grants in Cancer Research Funding Opportunity (UC CRCC)
Required LOI due January 24, 2023 (12 pm PST); Full Proposals Due April 13, 2023 (12 pm PST) Applicant webinar on January 11, 2023 at 1:30 pm PST.
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
PAR-23-058. Multiple application due dates. Expiration date January 8, 2026.
CFCCC Pilot Awards funded by the Anti-Cancer Challenge
The Chao Family Comprehensive Cancer Center (CFCCC) Anti-Cancer Challenge (ACC) is accepting applications for cancer-related pilot projects. Applications are due by February 23, 2024 (5:00 pm PST).
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
PAR-21-341. Multiple application deadlines. Expiration date October 9, 2024.
Co-infection and Cancer (R01 Clinical Trial Not Allowed)
PAR-23-055. Multiple application due dates. Expiration date November 6, 2025.
Co-infection and Cancer (R21 Clinical Trial Not Allowed)
PAR-23-056. Multiple application due dates. Expiration date November 17, 2025.
National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
PAR-23-059. Multiple application due dates. Expiration date May 08, 2026.
Applied Regulatory Science Research to Understand Factors that Affect the Safety and Efficacy of Underrepresented Populations in Oncology Therapeutic Development (U01) Clinical Trial Optional
RFA-FD-23-006. Applications due February 22, 2023.
HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)
RFA-NS-22-022. Multiple application deadlines. Expiration date March 12, 2025.
Team Funds
The Anti-Cancer Challenge (ACC), which is a ride, run and walk, raises awareness and funds for pilot studies and early-phase clinical trials that support cancer research at the UCI Chao Family Comprehensive Cancer Center.
HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
RFA-NS-22-023. Multiple application deadlines. Expiration date March 12, 2025
HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)
RFA-NS-22-024. Multiple application due dates. Expiration date March 12, 2025.
HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
RFA-NS-22-025. Multiple application due dates. Expiration date March 12, 2025.
Research Professor Grants (ACS)
Investigators who are full professors and made seminal contributions that have changed the direction of cancer care research and who expect to continue to provide leadership in their research area. This call is repeated once a year. LOI (required) due February 1, 2023. Applications due April 1, 2023.